Almost no independent research has investigated the potential health impacts of long-term feminine hygiene product use. Studies have generally taken place through product manufacturers—who aren’t required to release the results in full to the public.
A case in which an Ebola survivor appears to have transmitted the virus to his female partner many months after recovery has health experts changing their advice.
The report from the Kaiser Family Foundation finds that insurers are not providing consistent coverage for non-pill birth control methods, and it can be fiendishly difficult to find information about which methods are covered.
Genetic conditions have made their way into public dialogue in recent years, but not many people understand the decisions patients, particularly women, have to make once they have their diagnosis.
In an order issued late on April 15, the justice stayed a decision by the U.S. Court of Appeals for the Third Circuit in Zubik v. Burwell.
A small human study has found that infusing a person’s blood with HIV antibodies can cut the amount of virus in their body even if they are not taking antiretroviral drugs.
Even in states that allow for private insurance coverage of abortion, figuring out the details of that coverage can include many hurdles.
Reproductive rights advocates were disappointed Tuesday when the U.S. Senate passed a bill reforming Medicare payments that also included Hyde Amendment language.
HB 3183 would strike a line in the state’s advance directives code that bars the code from applying in cases where a patient is pregnant. Had such a law been in place in 2013, Marlise Muñoz’s family would have been allowed to refuse mechanical support for her corpse.
The Department of Health and Human Services, despite pressure from advocates and members of Congress, will not allow uninsured women to enroll in the Affordable Care Act (ACA) if they become pregnant outside of the three-month window of open enrollment.